Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Galectin 3”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06154954
What this trial is testing

Testicular Proteins for Sperm Retrieval Prediction Protein1, Testis-Expressed Gene 101, and Lectin Galactoside-binding Protein in Predicting Surgical Sperm Retrieval in Men With Non-Obstructive Azoospermia

Who this might be right for
Non-obstructive Azoospermia
Cairo University 90
Not applicableUnknownNCT02804321
What this trial is testing

Plasma Aldosterone Levels and Atrial Fibrillation Reduction (ALDO-AF Study)

Who this might be right for
Atrial FibrillationAldosterone
University Hospital, Caen 170
Testing effectiveness (Phase 2)UnknownNCT05240131
What this trial is testing

Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).

Who this might be right for
Non-Small Cell Lung Cancer
Galecto Biotech AB 88
Not applicableStudy completedNCT01210157
What this trial is testing

Galectin-3 Binding Protein in Cardiovascular Disease and Chronic Heart Failure

Who this might be right for
Heart FailureCardiomyopathiesCoronary Artery Disease
Heidelberg University 373
Not applicableUnknownNCT05699590
What this trial is testing

Galectin-3 in Papillary Thyroid Carcinoma

Who this might be right for
Galactin 3-thyroid Carcinoma
Sohag University 60
Testing effectiveness (Phase 2)Study completedNCT06398821
What this trial is testing

G3P-01 in Volunteers With Elevated Galectin-3

Who this might be right for
Galectin 3Healthy Aging
General Practitioners Research Institute 48
Not applicableUnknownNCT02814903
What this trial is testing

ALDOsterone for Prediction of Post-Operative Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
University Hospital, Caen 500
Testing effectiveness (Phase 2)Ended earlyNCT01723813
What this trial is testing

Peptide Vaccinations Plus GM-CT-01 in Melanoma

Who this might be right for
Metastatic Melanoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 6
Not applicableUnknownNCT03212612
What this trial is testing

Galectin-3 in Patients With Endometriosis

Who this might be right for
Endometriosis
Assiut University 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT05913388
What this trial is testing

GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma

Who this might be right for
Metastatic MelanomaHead and Neck Squamous Cell Carcinoma
Providence Health & Services 12
Early research (Phase 1)Study completedNCT02117362
What this trial is testing

Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Providence Health & Services 8
Not applicableLooking for participantsNCT07485114
What this trial is testing

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Non Small Cell Lung CancerHepatocellular Carcinoma+1 more
Daniel Keizman 300
Testing effectiveness (Phase 2)WithdrawnNCT04607655
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Galecto Biotech AB
Large-scale testing (Phase 3)UnknownNCT02800629
What this trial is testing

Blocking Extracellular Galectin-3 in Patients With Osteoarthritis

Who this might be right for
Osteoarthritis
Massachusetts General Hospital 50
Not applicableUnknownNCT05992727
What this trial is testing

Evaluation of Galectin-3 in Serum and Saliva of Pemphigus Patients

Who this might be right for
Galectin-3 and Pemphigus
Assiut University 60
Not applicableStudy completedNCT04573452
What this trial is testing

Galectin-3 and Placenta Accreta

Who this might be right for
Placenta Accreta
Assiut University 62
Not applicableNot Yet RecruitingNCT07683598
What this trial is testing

DLBS1033 as Adjunctive Therapy for Patients With Diabetic Neuropathy

Who this might be right for
Diabetic Neuropathy
RS H Adam Malik 80
Not applicableStudy completedNCT01842854
What this trial is testing

Galectin-3 as a Biomarker in Patients With Chagas Disease

Who this might be right for
Chagas Disease
Hospital Sao Rafael 60
Not applicableUnknownNCT05246215
What this trial is testing

Diagnostic Values of Galectin-3, Soluble ST2 and BNP in Predicting the Clinical Outcome of ST-Segment Elevation Myocardial Infarction Patients

Who this might be right for
ST Elevation Myocardial InfarctionHF - Heart FailureStable Angina
Assiut University 90
Testing effectiveness (Phase 2)Study completedNCT03832946
What this trial is testing

Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Galecto Biotech AB 172
Next Page